Cell-Easy

About

Cell-Easy is a French Contract Development and Manufacturing Organization (CDMO) based in Toulouse, specializing in cell therapy. Founded in 2018, the company focuses on advancing cell-based therapies, including immune cells and various types of stem cells, for applications in immuno-oncology and regenerative medicine. The company offers comprehensive solutions for cell therapy development and manufacturing, emphasizing GMP compliance and scalability. Their services include process development and scale-up, GMP manufacturing of ready-to-inject cell therapies, analytical services for quality control, and regulatory support for clinical trials. Cell-Easy has produced over 1000 clinical doses across multiple cell types and has established partnerships for clinical trials, including collaborations with Toulouse University Hospital. With a team that boasts over 300 years of combined expertise in cell culture, Cell-Easy is dedicated to ensuring product safety, quality, and efficacy while supporting clients in the biotechnology and pharmaceutical sectors globally. The company has raised significant funding to enhance its capabilities and expand its facilities.